This study describes the successful synthesis of nitric oxide (NO)-releasing compounds with biodegradable and injectable properties and demonstrates that the kinetics of NO release vary according to the type of NO donor. The antimicrobial activity of NO-releasing compounds against three common periodontal pathogens, i.e., Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, and Actinomyces israelii, was investigated using a susceptibility assay. Human gingival fibroblasts were treated with NO-releasing compounds at the minimum concentrations required for bacterial growth and cytotoxicity was evaluated using the MTT cell proliferation assay. Our results suggest that NO-releasing compounds can be used topically to treat both gram-negative and gram-positive periodontal pathogens. Comparison of the antimicrobial activity and cytotoxicity assay results between the NO-releasing compounds revealed that an NO donor comprising a macromolecule without surface charge, a lower instantaneous NO concentration, and an adequate supply of NO were associated with a strong bactericidal effect and low cytotoxicity. NO-releasing compounds with these properties may be suitable for treatment of periodontitis.

No abstract

BackgroundThe bacterial genus Mycobacterium is of great interest in the medical and biotechnological fields. Despite a flood of genome sequencing and functional genomics data, significant gaps in knowledge between genome and phenome seriously hinder efforts toward the treatment of mycobacterial diseases and practical biotechnological applications. In this study, we propose the use of systematic, comparative functional pan-genomic analysis to build connections between genomic dynamics and phenotypic evolution in polycyclic aromatic hydrocarbon (PAH) metabolism in the genus Mycobacterium.ResultsPhylogenetic, phenotypic, and genomic information for 27 completely genome-sequenced mycobacteria was systematically integrated to reconstruct a mycobacterial phenotype network (MPN) with a pan-genomic concept at a network level. In the MPN, mycobacterial phenotypes show typical scale-free relationships. PAH degradation is an isolated phenotype with the lowest connection degree, consistent with phylogenetic and environmental isolation of PAH degraders. A series of functional pan-genomic analyses provide conserved and unique types of genomic evidence for strong epistatic and pleiotropic impacts on evolutionary trajectories of the PAH-degrading phenotype. Under strong natural selection, the detailed gene gain/loss patterns from horizontal gene transfer (HGT)/deletion events hypothesize a plausible evolutionary path, an epistasis-based birth and pleiotropy-dependent death, for PAH metabolism in the genus Mycobacterium. This study generated a practical mycobacterial compendium of phenotypic and genomic changes, focusing on the PAH-degrading phenotype, with a pan-genomic perspective of the evolutionary events and the environmental challenges.ConclusionsOur findings suggest that when selection acts on PAH metabolism, only a small fraction of possible trajectories is likely to be observed, owing mainly to a combination of the ambiguous phenotypic effects of PAHs and the corresponding pleiotropy- and epistasis-dependent evolutionary adaptation. Evolutionary constraints on the selection of trajectories, like those seen in PAH-degrading phenotypes, are likely to apply to the evolution of other phenotypes in the genus Mycobacterium.Electronic supplementary materialThe online version of this article (doi:10.1186/s12862-015-0302-8) contains supplementary material, which is available to authorized users.

This experiment was performed to examine the hypothesis that blood plasma (BP) with yeast (Saccharomyces cerevisiae) supplement in the diet of weaning pigs could provoke the growth performance, nutrient digestibility, fecal microbial, and reduce harmful gas excretion. A total of one hundred and eighty healthy piglets were taken and assigned (complete random blocks) to three dietary treatments as: Phase 1: Treatment (TRT) 1-6% BP; TRT 2-3% BP + 3% yeast; TRT 3-6% yeast. Phase 2: TRT 1-3%; BP., TRT 2-1.5% BP + 1.5% yeast; TRT 3- 3% yeast. Phase 3: TRT 1- Control (CON) (Basal diet); TRT 2- CON; TRT 3- CON for six- weeks. Each treatment had twelve replicates and five (three gilts and two barrows) pigs per pen. Dietary inclusion of BP with yeast supplementation significantly increased the body weight of piglets during phase 2 (p = 0.003) and phase 3 (p = 0.032). In addition, TRT2 group piglets had a significant improvement in average daily gain at the end of each phase and overall (p = 0.047, 0.025, 0.018 and 0.012, respectively). At phase 3, TRT2 group piglets showed a significant improvement on nutrient digestibility of dry matter (p = 0.012) and nitrogen (p = 0.040). The fecal microbiota of TRT2 group piglets showed a tendency to increase the number of Lactobacillus counts at phase 1 (p = 0.07) and phase 2 (p = 0.06) as well as, a significant improvement at phase 3 (p = 0.021). In addition, TRT2 group piglets had trend to decrease NH3 (p = 0.074) and H2S (p = 0.069) during phase 2, and significantly reduced NH3 (p = 0.038) and H2S (p = 0.046) at phase 3. However, the fecal score of piglets remains unaffected during the entire trial. At the end of phase 1 piglets’ IgG (p = 0.008) was significantly increased with the inclusion of BP with yeast supplementation. Based on the positive effects on body weight, average daily gain, nutrient digestibility, Lactobacillus count, and reduced gas emission, we suggest that dietary supplement with BP and yeast in the diet of weaned piglet could serve as an excellent alternative to antibiotics growth promoters.

Antibiotics have great functions in farm animal. However, the harm of antibiotics can't be ignored. The effects of medium‐chain fatty acids (MCFAs) supplementation to basal diet instead of antibiotics (CSP, Chlortetracycline, sulphonamide dimethazine and procaine penicillin, 1:1:1) on growth performance, nutrient digestibility and blood profile in growing pigs were studied. A total of 140 growing pigs (Landrace × Yorkshire × Duroc) with an average body weight of 27.84 ± 0.42 kg were allotted to four treatments of seven replicates/treatment and five pigs/replicate. The four experimental diets included: CON (basal diet, non‐antibiotic, negative control); CSP (CON + CSP 0.1%, positive control); M1 (CON + MCFA 0.15%) and M2 (CON + MCFA 0.3%). After 5 weeks, the fresh faecal and blood samples were collected from rectum and jugular vein respectively. The average daily gain (ADG) was significantly improved for pigs fed 0.3% MCFAs in relation to basal diet. Meanwhile, CSP supplementation had comparable effect on ADG. The lymphocyte percentage and IgG concentration were higher in blood of pigs‐fed MCFAs in relation to that of CON and CSP treatment while white blood cell and red blood cell were not affected. In relation to basal diet and CSP treatment, the digestibility of dry matter, nitrogen and gross energy (E) were unaffected with MCFAs supplementation. In conclusion, MCFAs improved growth performance on body weight gain and immune profile. Addition 0.3% MCFAs into the diet indicated that its partial positive effect as an alternative to antibiotic.

This research aimed to assess the impact of probiotic supplementation in the broiler diet on growth performance, nutrient utilization, noxious gas emissions, excreta micromiota and meat quality. One thousand six hundred and twenty male Ross 380 broilers (one‐day‐old, body weight, 42 ± 0.5 g and 5‐week trial) were arbitrarily chosen and assigned to three nutritive treatments (basal diet and basal diet included with 0.1%, and 0.2% probiotic mixture [Bacillus subtilis 7.0 × 107 cfu/g, Bacillus licheniformis 4.1 × 107 cfu/g]) with 30 duplicates (18 birds each). Probiotic inclusion linearly increased (p < 0.05) broiler body weight gain (BWG) during Phases 1, 2 and the overall period and decreased (p < 0.05) feed conversion ratio (FCR) linearly on Phase 2 and the overall period. However, feed intake (FI) and mortality rate remained unaffected (p > 0.05). Though nutrient digestibility of nitrogen (N) tendency to increase (p < 0.05), dry matter (DM) and energy (E) did not influence (p > 0.05). Inclusion of a probiotic supplement linearly increased (p < 0.05) Lactobacillus and reduced Salmonella (p < 0.05) counts in broilers. Moreover, broilers fed a diet supplement with probiotic addition linearly decreased (p < 0.05) NH3, H2S, C2O and acetic acid emissions. The graded level of probiotic addition linearly reduced (p < 0.05) cooking loss and the tendency to decrease (p < 0.05) weight of bursa of Fabricius, but had no effect (p > 0.05) on other meat quality measures. These findings indicated that increasing the level of probiotics in feed could improve growth efficiency, nutrient absorption, microbial index, meat quality and reduce gas emissions in broilers.

The results indicate that dietary supplementation with increasing levan-type fructan enhanced growth performance, improved nutrient digestibility, and increased faecal lactic acid bacteria counts in weaning pigs linearly. © 2017 Society of Chemical Industry.

No abstract